Literature DB >> 22240440

Extrarenal effects of aldosterone.

Aurelie Nguyen Dinh Cat1, Frederic Jaisser.   

Abstract

PURPOSE OF REVIEW: The renal distal tubule has been considered for a long time as the main cellular target of aldosterone, where the hormone enhances sodium reabsorption and potassium secretion. However, other cell types in nonepithelial tissues, such as the heart, the vessels, adipose tissue, and macrophages, are now also recognized as targets for aldosterone. The functions that aldosterone exerts in these nonclassical target tissues are still a matter of debate. This review will highlight the recent findings on the extrarenal effects of aldosterone. RECENT
FINDINGS: Numerous studies showed that aldosterone exerts profibrotic and proinflammatory effects, but one or more cofactors such as salt, angiotensin II, and oxidative stress are required. Moreover, inflammation and macrophage infiltration are a prerequisite to aldosterone-induced cardiac fibrosis. This underlines a key role for aldosterone and the mineralocorticoid receptor in macrophages. Inflammatory effects of aldosterone in vascular smooth muscle cells involve trafficking to lipid rafts/caveolae through receptor tyrosine kinases. Finally, a growing body of evidence indicates a prominent role of aldosterone/mineralocorticoid receptor in the metabolic syndrome, in insulin resistance, and in adipocyte biology.
SUMMARY: The idiom from Socrates, 'the more we learn, the less we know', can be applied to aldosterone with its different facets and its pleiotropic effects. There is clear evidence for rapid nongenomic effects of aldosterone, mineralocorticoid receptor-dependent and mineralocorticoid receptor-independent signaling, in the heart, the vessels, and other nonepithelial tissues, leading to inflammation, fibrosis, and progression of cardiovascular diseases including hypertension and metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22240440     DOI: 10.1097/MNH.0b013e32834fb25b

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  29 in total

1.  Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.

Authors:  Eve Maubec; Cédric Laouénan; Lydia Deschamps; Van Tuan Nguyen; Isabelle Scheer-Senyarich; Anne-Catherine Wackenheim-Jacobs; Maud Steff; Stéphanie Duhamel; Sarah Tubiana; Nesrine Brahimi; Stéphanie Leclerc-Mercier; Béatrice Crickx; Claudine Perret; Selim Aractingi; Brigitte Escoubet; Xavier Duval; Philippe Arnaud; Frederic Jaisser; France Mentré; Nicolette Farman
Journal:  J Invest Dermatol       Date:  2015-02-10       Impact factor: 8.551

Review 2.  The role of ENaC in vascular endothelium.

Authors:  Kristina Kusche-Vihrog; Pia Jeggle; Hans Oberleithner
Journal:  Pflugers Arch       Date:  2013-09-18       Impact factor: 3.657

3.  Role of smooth muscle cell mineralocorticoid receptor in vascular tone.

Authors:  Antoine Tarjus; Ekaterina Belozertseva; Huguette Louis; Soumaya El Moghrabi; Carlos Labat; Patrick Lacolley; Frédéric Jaisser; Guillaume Galmiche
Journal:  Pflugers Arch       Date:  2014-09-30       Impact factor: 3.657

Review 4.  Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

Authors:  Chirag H Mandavia; Annayya R Aroor; Vincent G Demarco; James R Sowers
Journal:  Life Sci       Date:  2012-11-09       Impact factor: 5.037

5.  Direct and Indirect Mineralocorticoid Effects Determine Distal Salt Transport.

Authors:  Andrew S Terker; Bethzaida Yarbrough; Mohammed Z Ferdaus; Rebecca A Lazelle; Kayla J Erspamer; Nicholas P Meermeier; Hae J Park; James A McCormick; Chao-Ling Yang; David H Ellison
Journal:  J Am Soc Nephrol       Date:  2015-12-28       Impact factor: 10.121

Review 6.  Renal mineralocorticoid receptor and electrolyte homeostasis.

Authors:  Andrew S Terker; David H Ellison
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-07-01       Impact factor: 3.619

7.  Left ventricular geometry and 24-h blood pressure profile in Cushing's syndrome.

Authors:  Eleonora Avenatti; Andrea Rebellato; Andrea Iannaccone; Marialberta Battocchio; Francesca Dassie; Franco Veglio; Alberto Milan; Francesco Fallo
Journal:  Endocrine       Date:  2016-05-14       Impact factor: 3.633

Review 8.  Aldosterone mediates cardiac fibrosis in the setting of hypertension.

Authors:  Feriel Azibani; Loubina Fazal; Christos Chatziantoniou; Jane-Lise Samuel; Claude Delcayre
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 9.  The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series).

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

10.  Inflammatory monocyte/macrophage modulation by liposome-entrapped spironolactone ameliorates acute lung injury in mice.

Authors:  Wen-Jie Ji; Yong-Qiang Ma; Xin Zhang; Li Zhang; Yi-Dan Zhang; Cheng-Cheng Su; Guo-An Xiang; Mei-Ping Zhang; Zhi-Chun Lin; Lu-Qing Wei; Peizhong P Wang; Zhuoli Zhang; Yu-Ming Li; Xin Zhou
Journal:  Nanomedicine (Lond)       Date:  2016-05-12       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.